New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Nearly half of high-risk prostate cancer patients classified as nonmetastatic by traditional imaging show metastases when ...

Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Prostate Cancer Therapeutics Market offers comprehensive insights into the market landscape, ...

An ultrasound test that takes less than 20 minutes could improve the accuracy of prostate cancer diagnosis, scientists say.

Abiraterone is under clinical development by Austhera BioSciences and currently in Phase II for Hormone-Sensitive Prostate Cancer.

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Amid rumors about Israeli PM Benjamin Netanyahu's prostate surgery, medical experts raise key questions about the procedure's ...

Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines under the ...

Greater investments in ongoing clinical trials and oncology research encourage innovation in the treatment, thus boosting the ...